164 related articles for article (PubMed ID: 16730136)
1. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies.
Salama JK; Mundt AJ; Roeske J; Mehta N
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1170-6. PubMed ID: 16730136
[TBL] [Abstract][Full Text] [Related]
2. Initial Report of Pencil Beam Scanning Proton Therapy for Posthysterectomy Patients With Gynecologic Cancer.
Lin LL; Kirk M; Scholey J; Taku N; Kiely JB; White B; Both S
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):181-189. PubMed ID: 26372435
[TBL] [Abstract][Full Text] [Related]
3. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer.
Beriwal S; Gan GN; Heron DE; Selvaraj RN; Kim H; Lalonde R; Kelley JL; Edwards RP
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):166-71. PubMed ID: 17321070
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies.
Mundt AJ; Lujan AE; Rotmensch J; Waggoner SE; Yamada SD; Fleming G; Roeske JC
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1330-7. PubMed ID: 11955746
[TBL] [Abstract][Full Text] [Related]
5. Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer.
Klopp AH; Moughan J; Portelance L; Miller BE; Salehpour MR; Hildebrandt E; Nuanjing J; D'Souza D; Souhami L; Small W; Gaur R; Jhingran A
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):83-90. PubMed ID: 23582248
[TBL] [Abstract][Full Text] [Related]
6. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.
Poorvu PD; Sadow CA; Townamchai K; Damato AL; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1262-8. PubMed ID: 23182395
[TBL] [Abstract][Full Text] [Related]
7. Extended-field intensity-modulated radiotherapy and concurrent cisplatin-based chemotherapy for postoperative cervical cancer with common iliac or para-aortic lymph node metastases: a retrospective review in a single institution.
Zhang G; Fu C; Zhang Y; Wang J; Qiao N; Yang Q; Cheng Y
Int J Gynecol Cancer; 2012 Sep; 22(7):1220-5. PubMed ID: 22854654
[TBL] [Abstract][Full Text] [Related]
8. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy.
Lazzari R; Riva G; Augugliaro M; Vavassori A; Dicuonzo S; Cattani F; Comi S; Colombo N; Jereczek-Fossa BA
Int J Gynecol Cancer; 2020 May; 30(5):607-612. PubMed ID: 32188626
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric predictors of duodenal toxicity after intensity modulated radiation therapy for treatment of the para-aortic nodes in gynecologic cancer.
Verma J; Sulman EP; Jhingran A; Tucker SL; Rauch GM; Eifel PJ; Klopp AH
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):357-62. PubMed ID: 24411609
[TBL] [Abstract][Full Text] [Related]
10. Extended field intensity modulated radiation therapy for gynecologic cancers: Is the risk of duodenal toxicity high?
Xu KM; Rajagopalan MS; Kim H; Beriwal S
Pract Radiat Oncol; 2015; 5(4):e291-7. PubMed ID: 25532491
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
Milby AB; Both S; Ingram M; Lin LL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
[TBL] [Abstract][Full Text] [Related]
12. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.
Small W; Mell LK; Anderson P; Creutzberg C; De Los Santos J; Gaffney D; Jhingran A; Portelance L; Schefter T; Iyer R; Varia M; Winter K; Mundt AJ
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):428-34. PubMed ID: 18037584
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of semiextended field intensity-modulated radiation therapy and concurrent cisplatin in locally advanced cervical cancer patients: An observational study of 10-year experience.
Lee J; Lin JB; Sun FJ; Chen YJ; Chang CL; Jan YT; Wu MH
Medicine (Baltimore); 2017 Mar; 96(10):e6158. PubMed ID: 28272204
[TBL] [Abstract][Full Text] [Related]
14. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy.
Mundt AJ; Mell LK; Roeske JC
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1354-60. PubMed ID: 12873680
[TBL] [Abstract][Full Text] [Related]
15. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies.
Roeske JC; Lujan A; Rotmensch J; Waggoner SE; Yamada D; Mundt AJ
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1613-21. PubMed ID: 11121668
[TBL] [Abstract][Full Text] [Related]
17. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms.
Heron DE; Gerszten K; Selvaraj RN; King GC; Sonnik D; Gallion H; Comerci J; Edwards RP; Wu A; Andrade RS; Kalnicki S
Gynecol Oncol; 2003 Oct; 91(1):39-45. PubMed ID: 14529660
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study.
Chan P; Yeo I; Perkins G; Fyles A; Milosevic M
Radiat Oncol; 2006 May; 1():13. PubMed ID: 16722546
[TBL] [Abstract][Full Text] [Related]
19. Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer?
Adli M; Mayr NA; Kaiser HS; Skwarchuk MW; Meeks SL; Mardirossian G; Paulino AC; Montebello JF; Gaston RC; Sorosky JI; Buatti JM
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):230-8. PubMed ID: 12909238
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies.
Wong E; D'Souza DP; Chen JZ; Lock M; Rodrigues G; Coad T; Trenka K; Mulligan M; Bauman GS
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):830-41. PubMed ID: 15708263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]